Details for New Drug Application (NDA): 207577
✉ Email this page to a colleague
The generic ingredient in VERARING is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.
Summary for 207577
| Tradename: | VERARING |
| Applicant: | Dr Reddys Labs Sa |
| Ingredient: | ethinyl estradiol; etonogestrel |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | RING;VAGINAL | Strength | 0.015MG/24HR;0.12MG/24HR | ||||
| Approval Date: | Dec 9, 2021 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
